StonvexLoading…
StonvexStonvexStonvexCore line items from REX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2021 2021-07-31 | Q2 2021 2021-04-30 | Q4 2020 2020-10-31 | Q3 2020 2020-07-31 |
|---|---|---|---|---|
Revenue | $359.72M | $164.04M | $246.69M | $122.48M |
Operating Income | $19.99M | $10.19M | $-577.00K | $-19.82M |
Net Income | $15.66M | $7.78M | $-542.00K | $-9.38M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $505.51M | $486.14M | $475.16M | $472.34M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $154.31M | $157.10M | $173.07M | $152.71M |
Free Cash Flow OCF − CapEx | $14.46M | $12.30M | $14.89M | $-14.73M |
Shares Outstanding | Not available | Not available | Not available | Not available |